Nostrum Laboratories (Five Abbreviated New Drug Applications) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Nostrum Laboratories (Five Abbreviated New Drug Applications) General Information

Description

A portfolio of five abbreviated new drug applications in Missouri, United States. The abbreviated new drug applications are indicted for the treatment of attention deficit disorders and narcolepsy attention deficit disorders in various dosage forms.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Kansas City, MO
  • United States
Primary Industry
Buildings and Property
Other Industries
Other Pharmaceuticals and Biotechnology
Other Healthcare Technology Systems
Acquirer
Breckenridge Pharmaceutical
Vertical(s)
TMT
Corporate Office
  • Kansas City, MO
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nostrum Laboratories (Five Abbreviated New Drug Applications) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Nostrum Laboratories (Five Abbreviated New Drug Applications)‘s full profile, request access.

Request a free trial

Nostrum Laboratories (Five Abbreviated New Drug Applications) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Nostrum Laboratories (Five Abbreviated New Drug Applications)‘s full profile, request access.

Request a free trial

Nostrum Laboratories (Five Abbreviated New Drug Applications) FAQs

  • Where is Nostrum Laboratories (Five Abbreviated New Drug Applications) headquartered?

    Nostrum Laboratories (Five Abbreviated New Drug Applications) is headquartered in Kansas City, MO.

  • What industry is Nostrum Laboratories (Five Abbreviated New Drug Applications) in?

    Nostrum Laboratories (Five Abbreviated New Drug Applications)’s primary industry is Buildings and Property.

  • Is Nostrum Laboratories (Five Abbreviated New Drug Applications) a private or public company?

    Nostrum Laboratories (Five Abbreviated New Drug Applications) is a Private company.

  • What is Nostrum Laboratories (Five Abbreviated New Drug Applications)’s current revenue?

    The current revenue for Nostrum Laboratories (Five Abbreviated New Drug Applications) is .

  • Who are Nostrum Laboratories (Five Abbreviated New Drug Applications)’s investors?

    Nostrum Laboratories has invested in Nostrum Laboratories (Five Abbreviated New Drug Applications).

  • When was Nostrum Laboratories (Five Abbreviated New Drug Applications) acquired?

    Nostrum Laboratories (Five Abbreviated New Drug Applications) was acquired on 03-Oct-2017.

  • Who acquired Nostrum Laboratories (Five Abbreviated New Drug Applications)?

    Nostrum Laboratories (Five Abbreviated New Drug Applications) was acquired by Breckenridge Pharmaceutical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process